Publishing research using ab63535? Please let us know so that we can cite the reference in this datasheet.

ab63535 has been referenced in 1 publication.

  • Zhang X  et al. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer. J Hematol Oncol 10:29 (2017). IHC-P ; Human . PubMed: 28114995

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"